Economic evaluation of the GENESIS-SEFH report of olaratumab with doxorubicin in soft tissue sarcoma in advanced stages
Objective: The economic evaluation of the drug olaratumab is carried out in the treatment of soft tissue sarcoma.Method: The data were analyzed following the recommendations contained in the MADRE program of the GENESIS-SEFH report model.Results: Progression free survival and overall survival res...
Gorde:
| Argitaratua izan da: | Farmacia Hospitalaria |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Sociedad Española de Farmacia Hospitalaria
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://www.redalyc.org/articulo.oa?id=365962347006 https://www.redalyc.org/journal/3659/365962347006/ https://www.redalyc.org/journal/3659/365962347006/html/ https://www.redalyc.org/journal/3659/365962347006/365962347006.epub https://www.redalyc.org/journal/3659/365962347006/movil |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|